首页> 中文期刊> 《国际检验医学杂志》 >C反应蛋白、淀粉酶及脂肪酶联合检测在急性胰腺炎早期诊断中的作用

C反应蛋白、淀粉酶及脂肪酶联合检测在急性胰腺炎早期诊断中的作用

         

摘要

目的:探讨针对急性胰腺炎患者开展 C 反应蛋白、淀粉酶与脂肪酶联合检测的早期诊断价值,以及对病变程度的评估效果。方法选取该院2012年3月至2014年3月收治的急性胰腺炎患者71例,其中轻型胰腺炎患者60例,重型胰腺炎患者11例,同时以30例非急性胰腺炎急腹症患者作为对照 A 组,并选取同期于本院体检合格的健康成年人50例作为对照 B 组。分别开展 C 反应蛋白、淀粉酶以及脂肪酶的临床检测,并将获取结果进行比较与分析。结果急性胰腺炎患者血清淀粉酶水平为(759.42±721.63)U/L,血清脂肪酶水平为(1624.34±1598.25)U/L,均高于对照 A 组与对照 B 组,差异有统计学意义(P <0.05)。但患者的 C 反应蛋白水平为(44.61±34.21)mg/L,与对照 B 组比较差异无统计学意义(P >0.05)。三种指标联合检测用于早期急性胰腺炎诊断的灵敏度为95.9%,特异度为100.0%,准 确 度为96.9%,均高于其他检测方式,差 异有统计学意义(P <0.05)。结论针对急性胰腺炎患者开展 C 反应蛋白、淀粉酶与脂肪酶联合检测,不但具有明确的早期诊断效果,而且对疾病程度的判断具有参考价值。%Objective To evaluate the diagnostic value of combined test of C-reactive protein,amylase and lipase for acute pan-creatitis patients in early stage,and its practicability in assessment of disease severity.Methods 71 cases of acute pancreatitis pa-tients in the hospital from March 2012 to March 2014 were enrolled in the study,including 60 cases of mild pancreatitis patients,11 cases of severe pancreatitis patients.Meanwhile,30 cases of non-acute pancreatitis patients were enrolled as Control Group A,and 50 cases of adults who underwent conventional examination and proved to be healthy were enrolled as Control Group B.Detection of C-reactive protein,amylase and lipase of these samples were performed and the results were recorded,compared and analyzed.Re-sults The serum amylase level of acute pancreatitis patients was (759.42±721.63)U/L,and serum lipase level were (1 624.34± 1 598.25)U/L,which were significantly higher than people in Control Group A and Control Group B,with statistical significance (P <0.05).However,C-reactive protein level of acute pancreatitis patients were (44.61±34.21)mg/L,which were not statistical-ly different compared with Control Group B.Combined test of the three indicators demonstrated that the sensitivity was 95.9%, specificity was 100% and accuracy was 96.9%,all of which were higher than other test combinations or singe test with statistical significance(P <0.05 ).Conclusion The combined test of C-reactive protein,amylase and lipase for acute pancreatitis patients doesn′t only improve early diagnostic efficiency,but also is helpful in disease severity judgment.

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号